Targacept, Inc.
91Patents
52Active
91Granted
45Portfolio score
Filing activity: Feb 21, 1997 → Aug 27, 2015 · 40 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6166048A | Pharmaceutical compositions for inhibition of cytokine production and secretion | Emerging Cross-Sectional Technologies | 98 | Expired |
| US6492399B1 | Pharmaceutical compositions and methods for use | Chemistry; Metallurgy | 85 | Expired |
| US6455554B1 | Oxopyridinyl pharmaceutical compositions and methods for use | Chemistry; Metallurgy | 62 | Expired |
| US6953855B2 | 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof | Chemistry; Metallurgy | 30 | Expired |
| US6274606A | Methods of treating central nervous system disorders with aryl substituted olefinic amine compounds | Chemistry; Metallurgy | 25 | Expired |
| US7981906B2 | (2S,3R)-N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl-benzofuran-2-carboxamide, novel salt forms, and methods of use thereof | Human Necessities | 24 | Active |
| US6417359B1 | Pharmaceutical compositions and methods for use | Human Necessities | 21 | Expired |
| US6624173B1 | Pharmaceutical compositions for treating and/or preventing CNS disorders | Chemistry; Metallurgy | 21 | Expired |
| US6310102A | Pharmaceutical compositions and methods for use | Chemistry; Metallurgy | 18 | Expired |
| US6232316A | Methods for treatment of CNS disorders | Chemistry; Metallurgy | 17 | Expired |
| US7067261B2 | Methods and compositions for treatment of central nervous system disorders | Physics | 16 | Expired |
| US6218383A | Pharmaceutical compositions for the prevention and treatment of central nervous system disorders | Human Necessities | 15 | Expired |
| US7425561B2 | 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof | Chemistry; Metallurgy | 15 | Active |
| US7459469B2 | Hydroxybenzoate salts of metanicotine compounds | Chemistry; Metallurgy | 14 | Active |
| US6603011B1 | 3-pyridinyl compounds | Human Necessities | 13 | Expired |
| US6555684B2 | Pyrimidinyl compounds for treatment of central nervous system disorders | Human Necessities | 13 | Expired |
| US6525065B1 | Pharmaceutical compositions and methods for effecting dopamine release | Chemistry; Metallurgy | 13 | Expired |
| US7767193B2 | 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof | Chemistry; Metallurgy | 13 | Active |
| US7214686B2 | Pharmaceutical compositions and methods for effecting dopamine release | Emerging Cross-Sectional Technologies | 12 | Expired |
| US6432975B1 | Pharmaceutical compositions and methods for use | Human Necessities | 12 | Expired |
| US6337351B1 | Pharmaceutical compositions and methods for use | Chemistry; Metallurgy | 11 | Expired |
| US8124618B2 | 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof | Chemistry; Metallurgy | 10 | Active |
| US8124619B2 | 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof | Chemistry; Metallurgy | 10 | Active |
| US9145396B2 | Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3ylvinyl)pyrimidine | Chemistry; Metallurgy | 10 | Active |
| US8084462B2 | 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof | Chemistry; Metallurgy | 10 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.